Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

On the basis of the now consolidated literature and clinical experience of focal therapies, the execution of partial prostatectomy/hemiprostatectomy with robot-assisted laparoscopic technique can be proposed in a well-selected cohort of patients. The hypothesis is that with this technique it is possible to achieve excellent levels of disease control, in terms of positive surgical margins (PSM) and biochemical recurrence of the disease (BCR), against a minimal impact as regards postoperative functional outcomes (continence and sexual power).

Trial Details

NCT ID
NCT05832736
Phase
NA
Sponsor
Fondazione del Piemonte per l'Oncologia
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Robotic hemi-prostatectomy with urethral preservation
Locations (sample)
  • Candiolo, TO, Italy|44.95858,7.59812

Key Eligibility Criteria

  • Signature of the informed consent and consent to the use of personal data
  • Prostate Specific Antigen (PSA) \< 20 ng/mL
  • Unilateral organ-confined disease on MRI (performed according to ESUR recommendations and reported according to PiRads V.2) or PET-PSMA (performed …
  • Histological diagnosis of acinar-type prostate cancer unilateral on target biopsy and/or standard biopsy with ISUP \< 3 and ipsilateral on imaging …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →